Marie Machouart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marie Machouart has a total of 298 co-authors. Here are the top co-authors by number of shared publications:
Anne Debourgogne
Structure de Parasitologie-Mycologie, Département de Microbiologie, Centre Hospitalo-Universitaire de Nancy (CHU-Nancy), Hôpitaux de Brabois, 11 allée du Morvan, 54511 Vandœuvre-les-Nancy, France
7 shared publications- Anne Debourgogne
A Laboratoire Hospitalier et Universitaire de Parasitologie-Mycologie, CH Andrée Rosemon et EA 3593, Faculté de Médecine, Université des Antilles et de la Guyane , Cayenne , French Guyana
6 shared publications A. Debourgogne
Structure de parasitologie-mycologie, département de microbiologie, centre hospitalo-universitaire de Nancy (CHU-Nancy), hôpitaux de Brabois, 11, allée du Morvan, 54511 Vandœuvre-lès-Nancy, France
4 shared publicationsJ. Collomb
Service de Parasitologie‐Mycologie, Hôpitaux de Nancy, CHU Brabois
4 shared publicationsAlexandre Rivier
Service de Parasitologie‐Mycologie, CHU de Nancy, Hôpital Brabois, Vandoeuvre‐les‐Nancy, France
3 shared publicationsCécile Gueidan
3 shared publications
Latest Publications
- Open Access
Cryptococcal Meningitis in Kidney Transplant Recipients: A Two-Decade Cohort Study in France
Cryptococcosis is the third most common cause of invasive fungal infection in solid organ transplant recipients and cryptococcal meningitis (CM) its main clinical presentation. CM outcomes, as well as its clinical features and radiological characteristics, have not yet been considered on a large scale in the context of kidney transplantation (KT). We performed a nationwide retrospective study of adult patients diagnosed with cryptococcosis after KT between 2002 and 2020 across 30 clinical centers in France. We sought to describe overall and graft survival based on whether KT patients with cryptococcosis developed CM or not. Clinical indicators of CNS involvement and brain radiological characteristics were assessed. Eighty-eight cases of cryptococcosis were diagnosed during the study period, with 61 (69.3%) cases of CM. Mortality was high (32.8%) at 12 months (M12) but not significantly different whether or not patients presented with CM. Baseline hyponatremia and at least one neurological symptom were independently associated with CM (p < 0.001). Positive serum cryptococcal antigen at diagnosis was also significantly associated with CM (p < 0.001). On magnetic resonance imaging (MRI), three patterns of brain injury were identified: parenchymal, meningeal, and vascular lesions. Although CM does not affect graft function directly, it entails a grim prognosis.
Open AccessCryptococcal Meningitis in Kidney Transplant Recipients: A Two-Decade Cohort Study in France
Cryptococcosis is the third most common cause of invasive fungal infection in solid organ transplant recipients and cryptococcal meningitis (CM) its main clinical presentation. CM outcomes, as well as its clinical features and radiological characteristics, have not yet been considered on a large scale in the context of kidney transplantation (KT). We performed a nationwide retrospective study of adult patients diagnosed with cryptococcosis after KT between 2002 and 2020 across 30 clinical centers in France. We sought to describe overall and graft survival based on whether KT patients with cryptococcosis developed CM or not. Clinical indicators of CNS involvement and brain radiological characteristics were assessed. Eighty-eight cases of cryptococcosis were diagnosed during the study period, with 61 (69.3%) cases of CM. Mortality was high (32.8%) at 12 months (M12) but not significantly different whether or not patients presented with CM. Baseline hyponatremia and at least one neurological symptom were independently associated with CM (p < 0.001). Positive serum cryptococcal antigen at diagnosis was also significantly associated with CM (p < 0.001). On magnetic resonance imaging (MRI), three patterns of brain injury were identified: parenchymal, meningeal, and vascular lesions. Although CM does not affect graft function directly, it entails a grim prognosis.
- 1 September 2016
- Published by Elsevier in Journal of Medical Mycology
- Vol. 26 (3) , 227-232
Du cochon d’Inde à l’Homme : épidémie de teigne à Trichophyton mentagrophytes var. porcellae dans les animaleries nancéiennes
- 1 September 2016
- Published by Elsevier in Journal of Medical Mycology
- Vol. 26 (3) , 227-232
Du cochon d’Inde à l’Homme : épidémie de teigne à Trichophyton mentagrophytes var. porcellae dans les animaleries nancéiennes
- 15 May 2016
- Published by Wiley in Environmental Microbiology Reports
- Vol. 8 (3) , 332-342
Emerging infections due to filamentous fungi in humans and animals: only the tip of the iceberg?
Summary: Over the last few decades, the number of patients susceptible to invasive filamentous fungal infections has steadily increased, especially in populations suffering from hematological diseases. The pathogens responsible for such mycoses are now quite well characterized, such as Aspergillus spp. – the most commonly isolated mold –, Mucorales, Fusarium spp., Scedosporium spp. or melanized fungi. An increase in the incidence of this category of ‘emerging’ fungi has been recently highlighted, evoking a shift in fungal ecology. Starting from these medical findings, taking a step back and adopt a wider perspective offers possible explanations of this phenomenon on an even larger scale than previously reported. In this review, we illustrate the link between emerging fungi in medicine and changes in ecology or human behaviours, and we encourage integrative approaches to apprehend the adverse effects of progress and develop preventive measures in vast domains, such as agriculture or medicine.
- 15 May 2016
- Published by Wiley in Environmental Microbiology Reports
- Vol. 8 (3) , 332-342
Emerging infections due to filamentous fungi in humans and animals: only the tip of the iceberg?
Summary: Over the last few decades, the number of patients susceptible to invasive filamentous fungal infections has steadily increased, especially in populations suffering from hematological diseases. The pathogens responsible for such mycoses are now quite well characterized, such as Aspergillus spp. – the most commonly isolated mold –, Mucorales, Fusarium spp., Scedosporium spp. or melanized fungi. An increase in the incidence of this category of ‘emerging’ fungi has been recently highlighted, evoking a shift in fungal ecology. Starting from these medical findings, taking a step back and adopt a wider perspective offers possible explanations of this phenomenon on an even larger scale than previously reported. In this review, we illustrate the link between emerging fungi in medicine and changes in ecology or human behaviours, and we encourage integrative approaches to apprehend the adverse effects of progress and develop preventive measures in vast domains, such as agriculture or medicine.
- 1 February 2016
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 22 (2) , 190.e1-190.e8
Is real-time PCR-based diagnosis similar in performance to routine parasitological examination for the identification of Giardia intestinalis , Cryptosporidium parvum / Cryptosporidium hominis and Entamoeba histolytica from stool samples? Evaluation of a new commercial multiplex PCR assay and literature review
- 1 February 2016
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 22 (2) , 190.e1-190.e8
Is real-time PCR-based diagnosis similar in performance to routine parasitological examination for the identification of Giardia intestinalis , Cryptosporidium parvum / Cryptosporidium hominis and Entamoeba histolytica from stool samples? Evaluation of a new commercial multiplex PCR assay and literature review
Optimising the diagnostic strategy for onychomycosis from sample collection to FUNGAL identification evaluation of a diagnostic kit for real‐time PCR
Summary: Onychomycosis is a common nail disorder mainly due to dermatophytes for which the conventional diagnosis requires direct microscopic observation and culture of a biological sample. Nevertheless, antifungal treatments are commonly prescribed without a mycological examination having been performed, partly because of the slow growth of dermatophytes. Therefore, molecular biology has been applied to this pathology, to support a quick and accurate distinction between onychomycosis and other nail damage. Commercial kits are now available from several companies for improving traditional microbiological diagnosis. In this paper, we present the first evaluation of the real‐time PCR kit marketed by Bio Evolution for the diagnosis of dermatophytosis. Secondly, we compare the efficacy of the kit on optimal and non‐optimal samples. This study was conducted on 180 nails samples, processed by conventional methods and retrospectively analysed using this kit. According to our results, this molecular kit has shown high specificity and sensitivity in detecting dermatophytes, regardless of sample quality. On the other hand, and as expected, optimal samples allowed the identification of a higher number of dermatophytes by conventional mycological diagnosis, compared to non‐optimal samples. Finally, we have suggested several strategies for the practical use of such a kit in a medical laboratory for quick pathogen detection.
Optimising the diagnostic strategy for onychomycosis from sample collection to FUNGAL identification evaluation of a diagnostic kit for real‐time PCR
Summary: Onychomycosis is a common nail disorder mainly due to dermatophytes for which the conventional diagnosis requires direct microscopic observation and culture of a biological sample. Nevertheless, antifungal treatments are commonly prescribed without a mycological examination having been performed, partly because of the slow growth of dermatophytes. Therefore, molecular biology has been applied to this pathology, to support a quick and accurate distinction between onychomycosis and other nail damage. Commercial kits are now available from several companies for improving traditional microbiological diagnosis. In this paper, we present the first evaluation of the real‐time PCR kit marketed by Bio Evolution for the diagnosis of dermatophytosis. Secondly, we compare the efficacy of the kit on optimal and non‐optimal samples. This study was conducted on 180 nails samples, processed by conventional methods and retrospectively analysed using this kit. According to our results, this molecular kit has shown high specificity and sensitivity in detecting dermatophytes, regardless of sample quality. On the other hand, and as expected, optimal samples allowed the identification of a higher number of dermatophytes by conventional mycological diagnosis, compared to non‐optimal samples. Finally, we have suggested several strategies for the practical use of such a kit in a medical laboratory for quick pathogen detection.
- 1 May 2015
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 305 (3) , 408-412
First unusual case of keratitis in Europe due to the rare fungus Metarhizium anisopliae
- 1 May 2015
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 305 (3) , 408-412
First unusual case of keratitis in Europe due to the rare fungus Metarhizium anisopliae
- 1 December 2014
- Published by Elsevier in Journal of Medical Mycology
- Vol. 24 (4) , 287-295
Molecular diagnosis of onychomycosis
- 1 December 2014
- Published by Elsevier in Journal of Medical Mycology
- Vol. 24 (4) , 287-295
Molecular diagnosis of onychomycosis
- Open Access
- 16 July 2014
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 59 (8) , 1095-1104
Increased Incidence and Characteristics of Alveolar Echinococcosis in Patients With Immunosuppression-Associated Conditions
Background. An increased incidence of alveolar echinococcosis (AE) in patients with immunosuppression (IS) has been observed; our aim was to study this association and its characteristics. Methods. Fifty AE cases with IS-associated conditions (ISCs) before or at AE diagnosis were collected from the French AE registry (1982–2012, 509 cases). There were 30 cancers, 9 malignant hematological disorders, 14 chronic inflammatory diseases, 5 transplants, and 1 case of AIDS; 9 patients had ≥2 ISCs. Characteristics of the 42 IS/AE cases and the 187 non-IS/AE cases diagnosed during the period 2002–2012 were statistically compared. Results. There was a significant increase in IS/AE cases over time. Risk factors did not differ between IS/AE and non-IS/AE patients. However, AE was more frequently an incidental finding (78% vs 42%) and was diagnosed at earlier stages (41% vs 23%) in IS/AE than in non-IS/AE patients. Serology was more often negative (14% vs 1%) and treatment efficacy was better (51% regression after 1-year treatment vs 27%) in IS/AE patients. All IS/AE patients but 7 took IS drugs; 7 received biotherapeutic agents. When not concomitant, AE occurred in IS patients within a 48-month median time period. Atypical presentation and abscess-, hemangioma-, and metastasis-like images delayed AE diagnosis in 50% of IS/AE patients, resulting in inappropriate treatment. Liver images obtained for 15 patients 1–5 years before diagnosis showed no AE lesions. Albendazole efficacy was good, but 19 of 48 treated patients experienced side effects. Conclusions. Patients with immunosuppression are at increased risk for occurrence, delayed diagnosis, and progression of AE.
- 16 July 2014
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 59 (8) , 1095-1104
Open AccessIncreased Incidence and Characteristics of Alveolar Echinococcosis in Patients With Immunosuppression-Associated Conditions
Background. An increased incidence of alveolar echinococcosis (AE) in patients with immunosuppression (IS) has been observed; our aim was to study this association and its characteristics. Methods. Fifty AE cases with IS-associated conditions (ISCs) before or at AE diagnosis were collected from the French AE registry (1982–2012, 509 cases). There were 30 cancers, 9 malignant hematological disorders, 14 chronic inflammatory diseases, 5 transplants, and 1 case of AIDS; 9 patients had ≥2 ISCs. Characteristics of the 42 IS/AE cases and the 187 non-IS/AE cases diagnosed during the period 2002–2012 were statistically compared. Results. There was a significant increase in IS/AE cases over time. Risk factors did not differ between IS/AE and non-IS/AE patients. However, AE was more frequently an incidental finding (78% vs 42%) and was diagnosed at earlier stages (41% vs 23%) in IS/AE than in non-IS/AE patients. Serology was more often negative (14% vs 1%) and treatment efficacy was better (51% regression after 1-year treatment vs 27%) in IS/AE patients. All IS/AE patients but 7 took IS drugs; 7 received biotherapeutic agents. When not concomitant, AE occurred in IS patients within a 48-month median time period. Atypical presentation and abscess-, hemangioma-, and metastasis-like images delayed AE diagnosis in 50% of IS/AE patients, resulting in inappropriate treatment. Liver images obtained for 15 patients 1–5 years before diagnosis showed no AE lesions. Albendazole efficacy was good, but 19 of 48 treated patients experienced side effects. Conclusions. Patients with immunosuppression are at increased risk for occurrence, delayed diagnosis, and progression of AE.
- 1 March 2014
- Published by Elsevier in Journal of Medical Mycology
- Vol. 24 (1) , 19-24
Characteristics of Pneumocystis pneumonia in Nancy from January 2007 to April 2011 and focus on an outbreak in nephrology
- 1 March 2014
- Published by Elsevier in Journal of Medical Mycology
- Vol. 24 (1) , 19-24
Characteristics of Pneumocystis pneumonia in Nancy from January 2007 to April 2011 and focus on an outbreak in nephrology
- Open Access
- 1 February 2014
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 52 (2) , 692-694
Primary Cerebral Alveolar Echinococcosis: Mycology to the Rescue
A case of primary cerebral alveolar echinococcosis with a favorable outcome is reported. A universal fungal PCR enabled this diagnosis, while the initial serological analysis remained noncontributive.
- 1 February 2014
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 52 (2) , 692-694
Open AccessPrimary Cerebral Alveolar Echinococcosis: Mycology to the Rescue
A case of primary cerebral alveolar echinococcosis with a favorable outcome is reported. A universal fungal PCR enabled this diagnosis, while the initial serological analysis remained noncontributive.